A woman presents for her annual cervical screening appointment. She currently has a 52 mg LNG-IUS and an etonogestrel implant in situ (dual method use...

Question

A woman presents for her annual cervical screening appointment. She currently has a 52 mg LNG-IUS and an etonogestrel implant in situ (dual method use for menstrual management). She asks if either device affects her screening results. What is the correct advice?

Accepted Answer

Neither device affects cervical screening; the smear can be performed normally

Answer

Both devices must be removed before screening

Answer

The implant affects cervical cytology

Answer

The LNG-IUS causes false-negative results

Answer

Screening is contraindicated with two hormonal methods

uk-dfsrh MCQ (SBA): Cervical Screening with Dual Hormonal Methods

A woman presents for her annual cervical screening appointment. She currently has a 52 mg LNG-IUS and an etonogestrel implant in situ (dual method use for menstrual management). She asks if either device affects her screening results. What is the correct advice?